Related Experiment Video
Updated: May 21, 2025

06:21
Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
Published on: May 10, 2024
605
GEMPAX, do we have another second-line option after mFOLFIRINOX in pancreatic cancer?
Kathleen Boyle1, Kimberly J Perez1,2
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Annals of Translational Medicine
|March 21, 2025
Abstract
No abstract available in PubMed .

